/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | DNAGinkgo Bioworks Hold |
|---|---|
| Last close | $10.76close 2026-11-03 |
| Change % | +9.24%close 2026-11-03 |
| Market cap | $686Mclose 2026-11-03 |
| P/E | loss, no P/E |
| Revenue | $170M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerExcludingAssessedTax As ofFY ending 2025-12-31 Filing10-K · 0001628280-26-012346 · filed 2026-02-26 Open the filing on EDGAR → |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | -25.1%FY to 2025-12-31 |
| Net income | $-313000⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 FilingDEF 14A · 0001628280-26-028377 · filed 2026-04-29 Open the filing on EDGAR →Open the XBRL payload →CiteGinkgo Bioworks Holdings, Inc. (DNA), us-gaap:NetIncomeLoss: -313,000 USD, fiscal year ended 2025-12-31. Form DEF 14A, accession 0001628280-26-028377, filed 2026-04-29. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001830214/us-gaap/NetIncomeLoss.json |
| Net margin | -0.2%FY to 2025-12-31 |
| EPS (diluted) | $-5.64⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001628280-26-012346 · filed 2026-02-26 Open the filing on EDGAR →Open the XBRL payload →CiteGinkgo Bioworks Holdings, Inc. (DNA), us-gaap:EarningsPerShareDiluted: -5.64 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001628280-26-012346, filed 2026-02-26. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001830214/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 1FY to 2025-12-31 |
| Altman Z-ScoreUNVALIDATED | -7.39FY to 2025-12-31 |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | open now |